Skip to Content
Business Wire

Wedgewood Pharmacy Appoints Veterinary Advisory Board

Wedgewood Pharmacy Appoints Veterinary Advisory Board

Wedgewood Pharmacy, the largest compounding pharmacy in the U.S. devoted to animal health, has created a Veterinary Advisory Board comprising 11 veterinarians. The goal of the Board is to support the company’s mission of improving the lives of animals and those who love them.

For more than 40 years, Wedgewood Pharmacy has focused on understanding the needs of veterinary customers and meeting those needs. The company’s regular cadence of listening to customers includes customer satisfaction, loyalty, and targeted special-interest surveys, listening to its sales and customer-care organizations, and third-party marketing research including focus groups. Creating this Board supports key pillars of the company’s strategy of being obsessed with helping veterinary professionals thrive, helping pet owners to elevate the care of their pets, and creating a stable regulatory environment for the critical role of compounding pharmacy in animal health.

Marcy A. Bliss, CEO, said, “The members of the advisory board, all accomplished veterinarians, have insight directly into the challenges, opportunities, and changing marketplace for professional animal-healthcare. The better we understand their unique perspectives and challenges, the better we can take quick, decisive steps and shape our company to support them. Wedgewood Pharmacy’s success can be attributed to being attuned and responsive to the needs of its customers and that focus is deeply embedded in our pharmacy’s culture. Working with the Board will help us to focus even more sharply on the priorities that matter to our prescribers, pet parents, and patients, which will result in new product development, more efficient work processes, happier veterinary professionals, and better patient health outcomes.”

Todd Marcum, DVM, co-founder and president of PetVet365, who will chair the Board, noted: “Wedgewood Pharmacy has been known for years in the veterinary profession as a veterinarian-friendly company. It has a very strong, open culture in which it is safe to give and receive feedback. I see the company as a very agile problem solver. It is no surprise that it has enthusiastically embraced taking the advice of this powerful, diverse group of veterinarians who are leaders in the veterinary business and profession, all early adopters, highly creative, and forward-looking. So, looking to the future, I see a broader role for Wedgewood Pharmacy’s participation with key issues that are of great import to the profession such as mental health and new ways of thinking about veterinary practice.”

The members of the Board include:

About Wedgewood Pharmacy

Wedgewood Pharmacy is the largest compounding pharmacy devoted to animal-health in the U.S. Compounding is the long-established tradition in pharmacy practice that enables practitioners to prescribe and patients to take medicines that are specially prepared by pharmacists to meet patients' individual needs. A growing number of patients have unique health needs that off-the-shelf prescription medicines cannot meet. For them, customized, compounded medications prescribed or ordered by licensed physicians or veterinarians and mixed safely by trained, licensed compounding pharmacists are the only way to better health.

Compounded medications are created and prepared by specially trained pharmacists and pharmacy technicians in state-regulated pharmacies when mass-manufactured drugs are not, according to a prescriber, available or are not appropriate for a patient. The company’s 503B Outsourcing Facility, Wedgewood Connect, compounds medications under FDA’s modified cGMP standards.

Today’s Wedgewood Pharmacy grew from a local community pharmacy to become one of the largest compounding pharmacies in the United States. It is the leading pharmacy brand in animal health, recognized by 99% of veterinarians, and used by 8 in 10 veterinarians within the past year. It also prepares compounded medications for the human-health medical specialties of Addiction Medicine Urology, and Ophthalmology. The company serves more than 50,000 prescribers and hundreds of thousands of patients throughout the U.S. every year.

George (late) and Lucy Malmberg, both pharmacists, purchased Wedgewood Pharmacy in 1981; the year after the pharmacy opened. In June 2016, New Harbor Capital became the majority shareholder of the company. In 2018, the company acquired Diamondback Drugs. In 2020, the company purchased and began production at Wedgewood Connect, an FDA-registered 503B Outsourcing Facility, in San Jose, California. In the same year, the company acquired Wildlife Pharmaceuticals and ZooPharm, in Colorado and Wyoming, respectively. In early 2021, Partners Group, on behalf of its clients, acquired a majority interest in the company from New Harbor Capital.

Wedgewood Pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB®) for compliance with PCAB and other nationally recognized compounding standards. PCAB was formed by eight of the nation’s leading pharmacy associations and is a service of Accreditation Commission for Health Care. As a third-party accreditation organization, PCAB has developed the highest national standards against which providers are measured to demonstrate their ability to effectively and efficiently deliver quality compounded medications to consumers.

Wedgewood Pharmacy employs more than 800 people.

About Partners Group

Partners Group is a leading global private-markets firm. Since 1996, the firm has invested over USD 150 billion in private equity, private real estate, private debt, and private infrastructure on behalf of its clients globally. Partners Group seeks to generate superior returns through capitalizing on thematic growth trends and transforming attractive businesses and assets into market leaders. The firm is a committed, responsible investor and aims to create sustainable returns with lasting, positive impact for all its stakeholders. With over USD 119 billion in assets under management as of December 31, 2020, Partners Group provides an innovative range of bespoke client solutions to institutional investors, sovereign wealth funds, family offices, and private individuals globally. The firm employs more than 1,500 diverse professionals across 20 offices worldwide and has regional headquarters in Baar-Zug, Switzerland; Denver, USA; and Singapore. It has been listed on the SIX Swiss Exchange since 2006 (symbol: PGHN). For more information, please visit www.partnersgroup.com or follow the company on LinkedIn or Twitter.

Wedgewood Pharmacy
Marcy A. Bliss
Chief Executive Officer
MBliss@wedgewoodpharmacy.com
856-832-1303

PR Firm
David Kirk
DavidKirk@thePRguy.com
480-270-9631

Partners Group
Henry Weston
henry.weston@partnersgroup.com
44-207-575-2593

View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005229/en/